Supporting general health and wellbeing
The evidence architecture does not yet exist to say what BPC-157 does in humans, at what dose, for what indication, over what time frame, or in which populations
The performance of model-based versus rule-based phase I clinical trials in oncology
Glycine is included as a stabilizer in many compounded formulations, and it does not alter the fundamental storage requirements
Clinical Pharmacokinetics and Pharmacodynamics of Saxagliptin, a Dipeptidyl Peptidase-4 Inhibitor
For athletes, bodybuilders, and active adults who have been watching the injectable GLP-1 phenomenon from the sidelines, concerned about needles, muscle loss, or the commitment of weekly injections, this is a pivotal moment